Legend Biotech
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Legend Biotech's past years’ income statements indicate that its last revenue has increased compared to the previous period by 144% to $285,143,000. Profit margin reached -182%. Total operating expenses were $140,929,000.

Profit Margin

Legend Biotech Corporation (NASDAQ:LEGN): Profit margin
2017 23.59M 9.36M 39.69%
2018 49.13M -2.78M -5.67%
2019 57.26M -132.97M -232.21%
2020 75.67M -303.47M -401.02%
2021 89.79M -386.20M -430.12%
2022 117.00M -446.34M -381.48%
2023 285.14M -518.25M -181.75%

LEGN Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
285.14M117.00M89.79M75.67M57.26M49.13M23.59M
Cost of revenue
144.21M65.36M313.34M232.16M00-96K
Gross profit
140.92M51.64M-223.55M-156.48M57.26M49.13M23.69M
Operating exp.
Research and development
382.21M335.64M313.34M232.16M161.94M60.63M8.19M
Selling and marketing
94.15M93.41M102.54M49.57M25.62M1.16M-217K
Total operating expenses
140.92M509.69M462.82M304.87M192.63M64.20M9.59M
Operating income
-439.48M-455.82M-393.02M-313.34M-130.87M-1.53M13.78M
Other income (expenses), net
-80.63M10.10M6.81M-78.40M501K7.32M-40K
Income before tax
-520.11M-445.72M-386.20M-307.62M-130.37M-1.61M13.83M
Income tax expense
-1.86M625K1K-4.14M2.60M1.16M4.47M
Net income
-518.25M-446.34M-386.20M-303.47M-132.97M-2.78M9.36M
Earnings per share
Basic EPS
-2.94-2.81-2.74-2.57-1.01-0.020.07
Diluted EPS
-2.94-2.81-2.74-2.57-1.01-0.020.07
Data sourceData sourceData sourceData source